Published in FASEB J on February 01, 2001
A critical analysis of current in vitro and in vivo angiogenesis assays. Int J Exp Pathol (2009) 2.24
Muscle satellite cells and endothelial cells: close neighbors and privileged partners. Mol Biol Cell (2007) 2.16
Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels. Am J Pathol (2009) 1.87
Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling. J Clin Invest (2012) 1.85
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer (2008) 1.84
Microfluidic system for formation of PC-3 prostate cancer co-culture spheroids. Biomaterials (2009) 1.54
Mural cell associated VEGF is required for organotypic vessel formation. PLoS One (2009) 1.48
CD34 Promotes Pathological Epi-Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy. PLoS One (2016) 1.40
Molecular basis for endothelial lumen formation and tubulogenesis during vasculogenesis and angiogenic sprouting. Int Rev Cell Mol Biol (2011) 1.36
Microfluidic devices for studying heterotypic cell-cell interactions and tissue specimen cultures under controlled microenvironments. Biomicrofluidics (2011) 1.29
The effect of FGF-1 loaded alginate microbeads on neovascularization and adipogenesis in a vascular pedicle model of adipose tissue engineering. Biomaterials (2010) 1.14
Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors. Biomaterials (2013) 1.14
A heterogeneous in vitro three dimensional model of tumour-stroma interactions regulating sprouting angiogenesis. PLoS One (2012) 1.12
Elongation, proliferation & migration differentiate endothelial cell phenotypes and determine capillary sprouting. BMC Syst Biol (2009) 1.10
Cellular and molecular regulation of spiral artery remodelling: lessons from the cardiovascular field. Placenta (2010) 1.09
In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform. Front Bioeng Biotechnol (2016) 1.04
Spatiotemporal control over growth factor signaling for therapeutic neovascularization. Adv Drug Deliv Rev (2007) 1.03
In vitro models of angiogenesis. World J Surg (2007) 1.02
Matrix-Bound VEGF Mimetic Peptides: Design and Endothelial Cell Activation in Collagen Scaffolds. Adv Funct Mater (2011) 1.01
Getting Tie(2)d up in angiogenesis. J Clin Invest (2002) 1.00
Microcomputed tomography characterization of neovascularization in bone tissue engineering applications. Tissue Eng Part B Rev (2008) 1.00
Molecular mediators of angiogenesis. J Burn Care Res (2010) 0.98
A system for the direct co-culture of endothelium on smooth muscle cells. Biomaterials (2005) 0.96
Efficient in vivo vascularization of tissue-engineering scaffolds. J Tissue Eng Regen Med (2010) 0.94
Controlled proteolytic cleavage site presentation in biomimetic PEGDA hydrogels enhances neovascularization in vitro. Tissue Eng Part A (2012) 0.94
Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesis. Graefes Arch Clin Exp Ophthalmol (2009) 0.94
N-cadherin levels in endothelial cells are regulated by monolayer maturity and p120 availability. Cell Commun Adhes (2008) 0.93
Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells. Am J Pathol (2006) 0.93
MMP-sensitive PEG diacrylate hydrogels with spatial variations in matrix properties stimulate directional vascular sprout formation. PLoS One (2013) 0.92
Growth hormone promotes lymphangiogenesis. Am J Pathol (2008) 0.92
Laminin alpha4-null mutant mice develop chronic kidney disease with persistent overexpression of platelet-derived growth factor. Am J Pathol (2009) 0.90
Pericytes modulate endothelial sprouting. Cardiovasc Res (2013) 0.89
Bronchial smooth muscle cells of asthmatics promote angiogenesis through elevated secretion of CXC-chemokines (ENA-78, GRO-α, and IL-8). PLoS One (2013) 0.87
Scaffold-free in vitro arterial mimetics: the importance of smooth muscle-endothelium contact. Tissue Eng Part A (2010) 0.87
Cellular uptake of functional nanogels prepared by inverse miniemulsion ATRP with encapsulated proteins, carbohydrates, and gold nanoparticles. Biomacromolecules (2009) 0.85
VEGF-mediated fusion in the generation of uniluminal vascular spheroids. Dev Dyn (2008) 0.85
Scaffold-free tissue engineering: organization of the tissue cytoskeleton and its effects on tissue shape. Ann Biomed Eng (2014) 0.84
Endothelial Cell Vascular Smooth Muscle Cell Co-Culture Assay For High Throughput Screening Assays For Discovery of Anti-Angiogenesis Agents and Other Therapeutic Molecules. Int J High Throughput Screen (2010) 0.83
Cell invasion in the spheroid sprouting assay: a spatial organisation analysis adaptable to cell behaviour. PLoS One (2014) 0.81
A bioreducible polymer for efficient delivery of Fas-silencing siRNA into stem cell spheroids and enhanced therapeutic angiogenesis. Angew Chem Int Ed Engl (2012) 0.81
Peritoneal morphologic changes in a peritoneal dialysis rat model correlate with angiopoietin/Tie-2. Pediatr Nephrol (2008) 0.81
Vascularization of three-dimensional collagen hydrogels using ultrasound standing wave fields. Ultrasound Med Biol (2011) 0.80
Comparison of mixed and lamellar coculture spatial arrangements for tissue engineering capillary networks in vitro. Tissue Eng Part A (2012) 0.80
Pericytes on the tumor vasculature: jekyll or hyde? Cancer Microenviron (2012) 0.80
Three-dimensional 10% cyclic strain reduces bovine aortic endothelial cell angiogenic sprout length and augments tubulogenesis in tubular fibrin hydrogels. J Tissue Eng Regen Med (2010) 0.79
IQGAP1 promotes the phenotypic switch of vascular smooth muscle by myocardin pathway: a potential target for varicose vein. Int J Clin Exp Pathol (2014) 0.79
Domains I and IV of annexin A2 affect the formation and integrity of in vitro capillary-like networks. PLoS One (2013) 0.78
Vascular endothelial growth factor reduces mural cell coverage of endothelial cells and induces sprouting rather than luminal division in an HT1080 tumour angiogenesis model. Int J Exp Pathol (2004) 0.78
Multitargeting strategy using lenvatinib and golvatinib: maximizing anti-angiogenesis activity in a preclinical cancer model. Cancer Sci (2015) 0.78
Sonic Hedgehog-activated engineered blood vessels enhance bone tissue formation. Proc Natl Acad Sci U S A (2012) 0.78
Inhibition of endothelial/smooth muscle cell contact loss by the investigational angiopoietin-2 antibody MEDI3617. Microvasc Res (2012) 0.78
The use of total human bone marrow fraction in a direct three-dimensional expansion approach for bone tissue engineering applications: focus on angiogenesis and osteogenesis. Tissue Eng Part A (2014) 0.77
CD45+ Cells Present Within Mesenchymal Stem Cell Populations Affect Network Formation of Blood-Derived Endothelial Outgrowth Cells. Biores Open Access (2015) 0.77
Umbilical Cord Blood-Derived Mononuclear Cells Exhibit Pericyte-Like Phenotype and Support Network Formation of Endothelial Progenitor Cells In Vitro. Ann Biomed Eng (2015) 0.77
Paeonol Inhibits Proliferation of Vascular Smooth Muscle Cells Stimulated by High Glucose via Ras-Raf-ERK1/2 Signaling Pathway in Coculture Model. Evid Based Complement Alternat Med (2014) 0.77
Encapsulation of adipose stromal vascular fraction cells in alginate hydrogel spheroids using a direct-write three-dimensional printing system. Biores Open Access (2013) 0.77
Regulation of vascular smooth muscle cell phenotype in three-dimensional coculture system by Jagged1-selective Notch3 signaling. Tissue Eng Part A (2014) 0.76
Poly(ethylene glycol) Hydrogel Scaffolds Containing Cell-Adhesive and Protease-Sensitive Peptides Support Microvessel Formation by Endothelial Progenitor Cells. Cell Mol Bioeng (2015) 0.76
Angiopoietins modulate endothelial adaptation, glomerular and podocyte hypertrophy after uninephrectomy. PLoS One (2013) 0.76
Increased antioxidant defense mechanism in human adventitia-derived progenitor cells is associated with therapeutic benefit in ischemia. Antioxid Redox Signal (2014) 0.76
Vascular smooth muscle cell optimization of vasculogenesis within naturally derived, biodegradable, hybrid hydrogel scaffolds. Plast Reconstr Surg (2013) 0.75
Facial cutaneo-mucosal venous malformations can develop independently of mutation of TEK gene but may be associated with excessive expression of Src and p-Src. J Negat Results Biomed (2017) 0.75
Angiogenic endothelial cell invasion into fibrin is stimulated by proliferating smooth muscle cells. Microvasc Res (2013) 0.75
3D co-culture model to analyze the crosstalk between endothelial and smooth muscle cells. Tissue Eng Part C Methods (2016) 0.75
Identification of a potent endothelium-derived angiogenic factor. PLoS One (2013) 0.75
Hepatic tumor growth: target for angiogenesis inhibition? World J Surg (2005) 0.75
Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res (2000) 3.14
Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J Cell Biol (1998) 2.89
Tensional forces in fibrillar extracellular matrices control directional capillary sprouting. J Cell Sci (1999) 2.71
Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Biol Chem (1993) 2.62
Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res (1996) 2.10
Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer (1999) 1.79
Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy. Br J Cancer (2010) 1.42
Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1. J Biol Chem (1997) 1.41
Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines. Biochem Biophys Res Commun (1998) 1.41
Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab Invest (1998) 1.40
Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis. Breast Cancer Res Treat (1995) 1.26
Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors. Angiogenesis (2001) 1.25
New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis. J Med Chem (2000) 1.21
Cyclic angiogenesis and blood vessel regression in the ovary: blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion. Lab Invest (1996) 1.15
Modulation of in vitro angiogenesis in a three-dimensional spheroidal coculture model for bone tissue engineering. Tissue Eng (2004) 1.13
Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res (1997) 1.10
Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol (1997) 1.09
Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood. Angiogenesis (2001) 1.08
The activin-binding protein follistatin regulates autocrine endothelial cell activity and induces angiogenesis. Lab Invest (1997) 1.03
Expression of biologically active isoforms of the tumor angiogenesis factor VEGF in Escherichia coli. Biochem Biophys Res Commun (1996) 0.95
Tubes, branches, and pillars: the many ways of forming a new vasculature. Circ Res (2001) 0.95
Active interaction of human A375 melanoma cells with the lymphatics in vivo. Histochem Cell Biol (2000) 0.95
VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane. Dev Biol (1996) 0.92
An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells. Proc Natl Acad Sci U S A (1998) 0.92
Basic fibroblast growth factor (bFGF) regulates the expression of the CC chemokine monocyte chemoattractant protein-1 (MCP-1) in autocrine-activated endothelial cells. Arterioscler Thromb Vasc Biol (1997) 0.91
Distinct activities of Bartonella henselae type IV secretion effector proteins modulate capillary-like sprout formation. Cell Microbiol (2009) 0.90
The pivotal role of VEGF in tumor angiogenesis: molecular facts and therapeutic opportunities. Cancer Metastasis Rev (1998) 0.87
Targeting of endothelial KDR receptors with 3G2 immunoliposomes in vitro. Biochim Biophys Acta (2000) 0.85
Fetal plasma levels of circulating endothelial cell adhesion molecules in normal and preeclamptic pregnancies. Eur J Obstet Gynecol Reprod Biol (1998) 0.85
The alpha-helical domain near the amino terminus is essential for dimerization of vascular endothelial growth factor. J Biol Chem (1998) 0.83
Prognostic value of angiogenesis in mammary tumors. Anticancer Res (1998) 0.81
Donor stromal cells from human blood engraft in NOD/SCID mice. Blood (2000) 0.80
Transcriptional regulation of the Ras-related protein TC21/R-Ras2 in endothelial cells. FEBS Lett (1997) 0.79
Novel antibodies directed against the extracellular domain of the human VEGF-receptor type II. Hybridoma (1997) 0.77
Chemiluminescence immunoassay for vascular endothelial growth factor (vascular permeability factor) in tumor-tissue homogenates. Clin Chem (1996) 0.77
Activated protein C resistance and factor V Leiden in patients with hemolysis, elevated liver enzymes, low platelets syndrome. Obstet Gynecol (1998) 0.77
Rapid identification of differentially expressed endothelial cell genes by RNA display. Biochem Biophys Res Commun (1995) 0.75
Molecular aspects of the neuronal noradrenaline transporter. J Neural Transm Suppl (1991) 0.75
Biochemical characterization and purification of the neuronal sodium-dependent noradrenaline transporter. J Neural Transm Suppl (1990) 0.75